ConductScience.org, home

Trial · NCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

NCT06294990, Phase 4, Recruiting, Lise Aksglæde

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Klinefelter Syndrome and Testosterone Treatment in Puberty. Trials, record NCT06294990. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06294990

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Klinefelter Syndrome and Testosterone Treatment in Puberty
NCT number
NCT06294990
Status
Recruiting
Phases
Phase 4
Enrollment
32 participants, estimated
Lead sponsor
Lise Aksglæde
Conditions
Klinefelter Syndrome
Interventions
Testosterone gel, Placebo
First posted
2024-03-06
Last updated
2025-02-19

Source ClinicalTrials.gov

Registered outcomes61

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChanges in body fat massBaseline and 1 and two yearsEvaluation of body fat percentage by whole body dual energy x-ray absorptiometry (DEXA) scan
SecondaryPubertal development and virilizationEvery three months for two yearsTanner genital (G) staging from G1 to G5. G1 is the prepubertal stage and G5 is the fully develloped stage.
SecondaryPubertal development and virilizationEvery three months for two yearsTanner pubic hair (PH) staging from PH1 to PH6. PH1 is the prepubertal stage and PH6 is the fully develloped stage.
SecondaryPubertal development and virilizationEvery three months for two yearsMeasurement of voice frequency using the app "Voice Analyst" (Speechtools Ltd.).
SecondaryPubertal development and virilizationEvery three months for two yearsEvaluation of testicular volume by palpation with orchidometer
SecondaryPubertal development and virilizationEvery three months for two yearsPresence of gynecomastia (yes/no)
SecondaryPubertal development and viriliztionEvery three months for two yearsMeasurement of luteinizing hormone (LH) (IU/L) in serum
SecondaryPubertal development and viriliztionEvery three months for two yearsMeasurement of serum concentration of testosterone (nmol/L)
SecondaryPubertal development and viriliztionEvery three months for two yearsMeasurement of folliclestimulating hormone (FSH) (IU/L) in serum
SecondaryPubertal development and viriliztionEvery three months for two yearsMeasurement of serum concentration of estradiol (pmol/L)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
40090688DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Line Angle MatchingSecondary outcomeConductCognition
Mental RotationSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06294990

GET https://conductscience.org/api/trials/v1/NCT06294990/registered?page=2